Chief Financial Officer / Head of Corporate Development
Elisabeth Leiderman serves as Chief Financial Officer and Head of Corporate Development at Decibel Therapeutics, bringing extensive experience in corporate finance and business development. She previously held senior positions at Fortress Biotech as Senior Vice President and Head of Corporate Develo